Similar results were reported in TRAIL resistant colon cancer cells treated with DuP-697.20 It’s likely that while these small molecules can enhance clustering, concomitant TRAIL binding is necessary to force DR5 into a signaling-competent conformational state. The gene discussed is TNFRSF10B; the disease is colonic neoplasm.